Bausch Health Cos Free Cash Flow 2010-2024 | BHC
Bausch Health Cos free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Bausch Health Cos Annual Free Cash Flow |
| 2023 |
817.00 |
| 2022 |
-946.00 |
| 2021 |
1,826.00 |
| 2020 |
830.00 |
| 2019 |
1,276.00 |
| 2018 |
1,378.00 |
| 2017 |
5,372.00 |
| 2016 |
2,051.00 |
| 2015 |
2,035.00 |
| 2014 |
3,512.00 |
| 2013 |
967.80 |
| 2012 |
641.00 |
| 2011 |
617.96 |
| 2010 |
261.41 |
| 2009 |
381.78 |
| Bausch Health Cos Quarterly Free Cash Flow |
| 2024-09-30 |
765.00 |
| 2024-06-30 |
431.00 |
| 2024-03-31 |
129.00 |
| 2023-12-31 |
817.00 |
| 2023-09-30 |
525.00 |
| 2023-06-30 |
285.00 |
| 2023-03-31 |
107.00 |
| 2022-12-31 |
-946.00 |
| 2022-09-30 |
-1,355.00 |
| 2022-06-30 |
-38.00 |
| 2022-03-31 |
-109.00 |
| 2021-12-31 |
1,826.00 |
| 2021-09-30 |
1,880.00 |
| 2021-06-30 |
735.00 |
| 2021-03-31 |
381.00 |
| 2020-12-31 |
830.00 |
| 2020-09-30 |
495.00 |
| 2020-06-30 |
341.00 |
| 2020-03-31 |
210.00 |
| 2019-12-31 |
1,276.00 |
| 2019-09-30 |
1,119.00 |
| 2019-06-30 |
676.00 |
| 2019-03-31 |
391.00 |
| 2018-12-31 |
1,378.00 |
| 2018-09-30 |
1,119.00 |
| 2018-06-30 |
591.00 |
| 2018-03-31 |
397.00 |
| 2017-12-31 |
5,372.00 |
| 2017-09-30 |
4,657.00 |
| 2017-06-30 |
1,147.00 |
| 2017-03-31 |
916.00 |
| 2016-12-31 |
2,051.00 |
| 2016-09-30 |
1,525.00 |
| 2016-06-30 |
988.00 |
| 2016-03-31 |
495.00 |
| 2015-12-31 |
2,035.00 |
| 2015-09-30 |
1,498.90 |
| 2015-06-30 |
789.00 |
| 2015-03-31 |
425.30 |
| 2014-12-31 |
3,512.00 |
| 2014-09-30 |
2,747.60 |
| 2014-06-30 |
688.70 |
| 2014-03-31 |
426.20 |
| 2013-12-31 |
967.80 |
| 2013-09-30 |
737.80 |
| 2013-06-30 |
561.00 |
| 2013-03-31 |
249.70 |
| 2012-12-31 |
641.00 |
| 2012-09-30 |
583.84 |
| 2012-06-30 |
463.37 |
| 2012-03-31 |
222.36 |
| 2011-12-31 |
617.96 |
| 2011-09-30 |
443.13 |
| 2011-06-30 |
279.01 |
| 2011-03-31 |
64.83 |
| 2010-12-31 |
261.41 |
| 2010-09-30 |
272.02 |
| 2010-06-30 |
155.71 |
| 2010-03-31 |
49.66 |
| 2009-12-31 |
381.78 |
| 2009-09-30 |
241.03 |
| 2009-06-30 |
147.73 |
| 2009-03-31 |
46.19 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.723B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
